C27H36N4O6S — CID 146596791
[(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid (PubChem CID 146596791) has the molecular formula C27H36N4O6S and a molecular weight of 544.67 g/mol. Its IUPAC name is [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid.
| Compound Name | [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid |
|---|---|
| PubChem CID | 146596791 |
| Molecular Formula | C27H36N4O6S |
| Molecular Weight | 544.67 g/mol |
| Exact Mass | 544.24 |
| IUPAC Name | [(2S)-1-[[(4S,7S,9aS)-8,8-dimethyl-5-oxo-7-[[(1S)-1-phenyl-2-prop-2-ynoxyethyl]carbamoyl]-2,3,4,7,9,9a-hexahydropyrrolo[2,1-b][1,3]thiazepin-4-yl]amino]-1-oxopropan-2-yl]-methylcarbamic acid |
| SMILES | C#CCOC[C@@H](NC(=O)[C@H]1N2C(=O)[C@@H](NC(=O)[C@H](C)N(C)C(=O)O)CCS[C@H]2CC1(C)C)c1ccccc1 |
| InChI | InChI=1S/C27H36N4O6S/c1-6-13-37-16-20(18-10-8-7-9-11-18)29-24(33)22-27(3,4)15-21-31(22)25(34)19(12-14-38-21)28-23(32)17(2)30(5)26(35)36/h1,7-11,17,19-22H,12-16H2,2-5H3,(H,28,32)(H,29,33)(H,35,36)/t17-,19-,20+,21-,22+/m0/s1 |
| InChIKey | GEFSRSARSDNUEO-TXZRGUEPSA-N |
| XLogP | 2.07 |
| TPSA | 128.28 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 38 |
| Complexity | — |
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 544.67 |
| LogP ≤ 5 | 2.07 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'} |
|---|